Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2019, Article ID 9851307, 5 pages
https://doi.org/10.1155/2019/9851307
Review Article

Direct Oral Anticoagulant Use and Risk of Diverticular Hemorrhage: A Systematic Review of the Literature

Department of Medicine, Memorial University of Newfoundland, Medical Education Centre, 300 Prince Philip Drive, St. John’s, NL, Canada A1B 3V6

Correspondence should be addressed to MacKenzie Turpin; ac.num@niprut.eiznekcam

Received 27 March 2019; Revised 27 May 2019; Accepted 11 June 2019; Published 18 June 2019

Academic Editor: Toshio Uraoka

Copyright © 2019 MacKenzie Turpin and Peter Gregory. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Canadian Cardiovascular Society, Focused Update of the Canadian Cardiovascular Society for the Management of Atrial Fibrillation, 2018.
  2. A. Lanas-Gimeno and A. Lanas, “Risk of gastrointestinal bleeding during anticoagulant treatment,” Expert Opinion on Drug Safety, vol. 16, no. 6, pp. 673–685, 2017. View at Publisher · View at Google Scholar
  3. L. Laine, H. Yang, S.-C. Chang, and C. Datto, “Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009,” American Journal of Gastroenterology, vol. 107, no. 8, pp. 1190–1195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. F. Longsreth, “Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study,” American Journal of Gastroenterology, vol. 97, pp. 419–424, 1997. View at Google Scholar
  5. J. N. Rubin, D. Shoag, J. N. Gaetano, D. Micic, and N. Sengupta, “Risk factors for 30-day hospital readmission for diverticular hemorrhage,” Journal of Clinical Gastroenterology, vol. 53, no. 4, pp. e133–e141, 2019. View at Publisher · View at Google Scholar
  6. R. K. Vajravelu, R. Mamtani, F. I. Scott, A. Waxman, and J. D. Lewis, “Incidence, risk factors, and clinical effects of recurrent diverticular hemorrhage: a large cohort study,” Gastroenterology, vol. 155, no. 5, pp. 1416–1427, 2018. View at Publisher · View at Google Scholar
  7. N. Nagata, R. Niikura, T. Aoki et al., “Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy,” Journal of Gastroenterology and Hepatology, vol. 29, no. 10, pp. 1786–1793, 2014. View at Publisher · View at Google Scholar
  8. M. Taki, T. Oshima, K. Tozawa et al., “Analysis of risk factors for colonic diverticular bleeding and recurrence,” Medicine, vol. 96, no. 38, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  9. A. Kumar, B. Disney, R. Hipkins et al., “The risk of gastrointestinal bleeding with novel oral anticoagulants in a large cohort of patients at a district general hospital,” United European Gastroenterology Journal, vol. 3, no. 5 Suppl 1, p. A284, 2015. View at Google Scholar
  10. J. H. Lai, S. Vaidya, S. Sudat, A. Pressman, and L. B. Gerson, “Prevalence and risk factors for gastrointestinal bleeding in novel oral anticoagulant users,” Gastroenterology, vol. 152, no. 5, pp. S475–S476, 2017. View at Publisher · View at Google Scholar
  11. M. M. Brodie, T. Smith, J. Newman, and D. C. Rockey, “Severity of gastrointestinal bleeding in patients treated with direct-acting oral anticoagulants,” The American Journal of Medicine, vol. 131, no. 5, pp. 573e10–573e15, 2017. View at Publisher · View at Google Scholar
  12. The EINSTEIN Investigators, “Oral rivaroxaban for symptomatic treatment of venous thromboembolism,” The New England Journal of Medicine, vol. 363, pp. 2499–2510, 2012. View at Google Scholar
  13. The EINSTEIN–PE Investigators, “Oral rivaroxban for symptomatic treatment of pulmonary embolism,” The New England Journal of Medicine, pp. 366–1287, 2012. View at Google Scholar
  14. M. R. Patel, K. W. Mahaffey, and J. Garg, “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” The New England Journal of Medicine, vol. 365, no. 24, pp. 883–891, 2011. View at Publisher · View at Google Scholar
  15. A. Jansen, S. Harenberg, U. Grenda, and C. Elsing, “Risk factors for colonic diverticular bleeding: a westernized community based hospital study,” World Journal of Gastroenterology, vol. 15, no. 4, pp. 457–461, 2009. View at Publisher · View at Google Scholar
  16. R. Niikura, N. Nagata, A. Yamada, J. Akiyama, T. Shimbo, and N. Uemura, “Recurrence of colonic diverticular bleeding and associated risk factors,” Colorectal Disease, vol. 14, no. 3, pp. 302–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Sugihara, S. E. Kudo, H. Miyachi et al., “Analysis of risk factors for colonic diverticular bleeding: a matched case-control study,” Gut and Liver, vol. 10, no. 2, pp. 244–249, 2016. View at Publisher · View at Google Scholar
  18. K. Kinjo, T. Matsui, T. Hisabe et al., “Increase in colonic diverticular hemorrhage and confounding factors,” World Journal of Gastrointestinal Pharmacology and Therapeutics, vol. 7, pp. 440–446, 2016. View at Publisher · View at Google Scholar